The story has been updated to include net loss from the first half of 2012 on an adjusted basis and to reflect that the company raised cash after the end of the recently completed period.

NEW YORK (GenomeWeb News) – Proteome Sciences today said that revenues for the first half of 2013 increased 10 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.